Narrow search
Showing 1 - 10 of 252
Cover Image
Work Productivity and Healthcare Resource Utilization Outcomes for Patients on Etanercept for Moderate-to-Severe Plaque Psoriasis: Results from a 1-Year, Multicentre, Open-Label, S...
Vender, Ronald; Lynde, Charles; Ho, Vincent; Chau, Dina; … - In: Applied Health Economics and Health Policy 10 (2012) 5, pp. 343-353
Background:Background: Data investigating the effect of etanercept on work productivity and healthcare resource … describe work productivity and healthcare resource utilization in patients with psoriasis prescribed etanercept. Abstract …-to-severe plaque psoriasis at baseline (Physician Global Assessment [PGA] ≥3, scale 0-5); able to start etanercept therapy as …
Persistent link: https://www.econbiz.de/10010567016
Cover Image
Cost Effectiveness of Prostacyclins in Pulmonary Arterial Hypertension
Roman, Antonio; Barberà, Joan A. Barber; Escribano, Pilar - In: Applied Health Economics and Health Policy 10 (2012) 3, pp. 175-188
Background:Background: Pulmonary arterial hypertension (PAH) is considered an orphan disease. Prostacyclins are the keystone for PAH treatment. Choosing between the three available prostacyclin therapies could be complicated because there are no comparison studies, so the final decision must be...
Persistent link: https://www.econbiz.de/10011005061
Cover Image
Cost-Effectiveness Analysis of Early versus Non-Early Intervention in Acute Migraine Based on Evidence from the 'Act when Mild' Study
Slof, John - In: Applied Health Economics and Health Policy 10 (2012) 3, pp. 201-215
Background:Background: In spite of the important progress made in the abortive treatment of acute migraine episodes since the introduction of triptans, reduction of pain and associated symptoms is in many cases still not as effective nor as fast as would be desirable. Recent research pays more...
Persistent link: https://www.econbiz.de/10011005063
Cover Image
A Cost-Utility Analysis of Cinacalcet in Secondary Hyperparathyroidism in Five European Countries
Iannazzo, Sergio; Carsi, Michela; Chiroli, Silvia - In: Applied Health Economics and Health Policy 10 (2012) 2, pp. 127-138
Background and Objective:Background and Objective: A probabilistic patient-level Markov model was previously developed to simulate lifetime clinical and economic outcomes of cinacalcet treatment in secondary hyperparathyroidism (SHPT) patients using local data from Italy. The present study...
Persistent link: https://www.econbiz.de/10009647777
Cover Image
Economic Evaluation of Clopidogrel in Acute Coronary Syndrome Patients without ST-Segment Elevation in Greece: A Cost-Utility Analysis
Kourlaba, Georgia; Fragoulakis, Vassilis; Maniadakis, Nikos - In: Applied Health Economics and Health Policy 10 (2012) 4, pp. 261-271
Background:Background: Current guidelines recommend treatment with antiplatelet and anticoagulant therapy for the secondary prevention of atherothrombotic events among patients with non-ST-segment elevation myocardial infarction (NSTEMI) or unstable angina (UA). The CURE (Clopidogrel in Unstable...
Persistent link: https://www.econbiz.de/10010552619
Cover Image
Cost Effectiveness of Tobacco Control Policies in Vietnam: The Case of Population-Level Interventions
Higashi, Hideki; Truong, Khoa D.; Barendregt, Jan J.; … - In: Applied Health Economics and Health Policy 9 (2011) 3, pp. 183-196
Background: Tobacco smoking is one of the leading public health problems in the world. It is also possible to prevent and/or reduce the harm from tobacco use through the use of cost-effective tobacco control measures. However, most of this evidence comes from developed countries and little...
Persistent link: https://www.econbiz.de/10010614256
Cover Image
Cost Effectiveness of Chemoprevention for Prostate Cancer with Dutasteride in a High-Risk Population Based on Results from the REDUCE Clinical Trial
Kattan, Michael W.; Earnshaw, Stephanie R.; McDade, … - In: Applied Health Economics and Health Policy 9 (2011) 5, pp. 305-315
Background: The REDUCE trial examined whether chemoprevention with the dual 5-alpha reductase inhibitor, dutasteride, reduced risk of prostate cancer (PCa) detection on biopsy. Objective: We examined the cost effectiveness of dutasteride compared with placebo in preventing PCa in men at...
Persistent link: https://www.econbiz.de/10010614259
Cover Image
Intra-Operative vs Pre-Operative Endoscopic Sphincterotomy in Patients with Gallbladder and Common Bile Duct Stones: Cost-Utility and Value-of-Information Analysis
Gurusamy, Kurinchi; Wilson, Edward; Burroughs, Andrew K.; … - In: Applied Health Economics and Health Policy 10 (2012) 1, pp. 15-29
Background: Patients with gallbladder and common bile duct stones are generally treated by pre-operative endoscopic sphincterotomy (ES) followed by laparoscopic cholecystectomy (POES). Recently, a meta-analysis has shown that intra-operative ES during laparoscopic cholecystectomy (IOES) results...
Persistent link: https://www.econbiz.de/10010614263
Cover Image
Cost Effectiveness of Secondary vs Tertiary Prevention for Post-Menopausal Osteoporosis
Mueller, Dirk; Gandjour, Afschin - In: Applied Health Economics and Health Policy 9 (2011) 4, pp. 259-273
Background: The aging of the population is likely to increase the number of osteoporosis-related fractures, such as hip fractures, and hence the economic burden for society. Therefore, strategies to identify women at increased risk are of major interest. Objective: The aim of this study was to...
Persistent link: https://www.econbiz.de/10010614268
Cover Image
Cost Effectiveness of Self-Monitoring of Blood Glucose (SMBG) for Patients with Type 2 Diabetes and Not on Insulin: Impact of Modelling Assumptions on Recent Canadian Findings
Tunis, Sandra L. - In: Applied Health Economics and Health Policy 9 (2011) 6, pp. 351-365
Background:Background: Canadian patients, healthcare providers and payers share interest in assessing the value of self-monitoring of blood glucose (SMBG) for individuals with type 2 diabetes but not on insulin. Using the UKPDS (UK Prospective Diabetes Study) model, the Canadian Optimal...
Persistent link: https://www.econbiz.de/10010614285